Tirzepatide

Product

Dual GLP-1/GIP receptor agonist sold as Mounjaro and Zepbound by Eli Lilly

3 stories

Scientists Identify Biological Mechanism Behind Why Ozempic Fails for Some Patients

Eli Lilly's Obesity Drug Retatrutide Succeeds in Late-Stage Diabetes Trial

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections